Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1995
11/15/1995EP0682027A1 Pyrrolopyrimidine derivatives with antiproliferative action
11/15/1995EP0682026A1 "Stable crystalline (6S)- and (6R)-tetrahydrofolic acid"
11/15/1995EP0682025A1 5,6-dihydro-4H-imidazo 2',1':2,3 imidazo 4,5,1-ij quinoline and 4,5-dihydroimidazo 1,2-a pyrrolo 1,2,3-cd benzimidazol derivatives
11/15/1995EP0682024A1 Cyclohexane derivatives, processes for their preparation and their use as glucose-6-phosphatase inhibitors
11/15/1995EP0682021A1 Benzimidazoles, medicines containing them and process for their preparation
11/15/1995EP0682017A1 Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents
11/15/1995EP0682016A1 Pyridine derivatives
11/15/1995EP0682015A1 Piperidine derivates and anti-platelet agents containing the same
11/15/1995EP0682009A2 Intermediate compounds for preparing endothelin-receptor antagonist triterpene derivatives
11/15/1995EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method
11/15/1995EP0681836A1 Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives
11/15/1995EP0681833A2 Nasally administrable compositions
11/15/1995EP0681831A2 Use of extracts of filamentous bacteria as cosmetic agents against skin aging
11/15/1995EP0681587A1 Side chain fluoro substituted 3-carboxysteroids
11/15/1995EP0681584A1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
11/15/1995EP0681571A1 Spiro-substituted azacycles as tachykinin receptor antagonists
11/15/1995EP0238545B1 C20 through c26 amino steroids
11/15/1995CN1111907A Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
11/15/1995CN1111638A Sulfated-glycolipid derivatives as cell adhesion inhibitors
11/15/1995CN1111632A Imidazodiazepine
11/15/1995CN1111626A Preparation and the pharmaceutical compositions which contain them
11/15/1995CN1111620A New alkylaminoindane compounds, processes for preparing them and pharmaceutical compositions containing them
11/15/1995CN1111618A Urea-subtituted benzoylguanidines, proces for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/1995CN1111513A Fungicidal compositions containing bifonazole
11/15/1995CN1111511A Combination treatment for osteoporosis
11/15/1995CN1111508A Fatty acid derivatives
11/15/1995CN1030253C Methylenebisphosphonic acid derivatives
11/15/1995CN1030252C Tetrahydrobenzimidazole derivative
11/15/1995CN1030251C Substituted 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives
11/14/1995US5466826 Process for preparing a physical form of pharmaceutical agent
11/14/1995US5466712 Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
11/14/1995US5466706 9H-imidazo[1,2-A]benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application
11/14/1995US5466701 Saccharin derivative proteolytic enzyme inhibitors
11/14/1995US5466699 (S)-N,N-dimethyl-2-(5-(2-oxo-1,3-oxazolidin -4-ylmethyl)-1H-indole-3-yl)ethylamine; zolmitriptan
11/14/1995US5466698 Substituted tetrahydrophyridines and hydroxypiperidines as central nervous system agents
11/14/1995US5466696 Tacrine and cytochrome P450 oxidase inhibitors and methods of use
11/14/1995US5466682 Bone disorders
11/14/1995US5466678 Potentiating antitumor activity
11/14/1995US5466596 Genetic engineering
11/12/1995CA2149092A1 Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene-derivatives
11/11/1995CA2148951A1 5,6-dihydro-4h-imidazo[2',1':2,3]imidazo-[4,5,1-ij] quinoline and 4,5-dihydroimidazo-[1,2-a]pyrrolo[1,2,3-cd] benzimidazole derivatives, their preparation and application in therapeutics
11/10/1995CA2148301A1 Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
11/09/1995WO1995029911A1 Benzofuran derivatives as d4 receptor antagonists
11/09/1995WO1995029909A1 Novel acyclic and cyclic amides as neurotransmitter release enhancers
11/09/1995WO1995029907A1 Benzofuran derivatives useful as inhibitors of bone resorption
11/09/1995WO1995029694A1 Collagen hydrolysis accelerator
11/09/1995WO1995029675A1 Method and composition for treating renal disease and failure
11/09/1995WO1995029672A1 HALOMETHYL AMIDES AS IL-1β PROTEASE INHIBITORS
11/09/1995WO1995029669A2 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995DE19515650A1 New 8-O-Methyl purpuro-galline carboxylic acid
11/09/1995CA2189070A1 Method and composition for treating renal disease and failure
11/09/1995CA2189036A1 Halomethyl amides as il-1.beta. protease inhibitors
11/09/1995CA2188949A1 Benzofuran derivatives as d4 receptor antagonists
11/09/1995CA2188569A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/08/1995EP0680972A1 Trifluoromethylketone peptide derivatives, process for their preparation and pharmaceutical compositions comprising them
11/08/1995EP0680962A2 Heterocyclic compounds
11/08/1995EP0680758A1 Pharmaceutical compositions containing tamoxifen or analogs and raloxifene or analogs
11/08/1995EP0680755A1 Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy
11/08/1995EP0680752A2 Conditioned water soluble substances
11/08/1995EP0680749A2 Cosmetic composition comprising an antagonist of substance P
11/08/1995EP0680745A2 Use of antifungals and or halogenated antibacterial agents for diminishing hair loss
11/08/1995EP0680489A1 Foldback triplex-forming oligonucleotides
11/08/1995EP0680472A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
11/08/1995EP0680470A1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents.
11/08/1995EP0680469A1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same
11/08/1995EP0680468A1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation
11/08/1995EP0680333A1 Prevention and treatment of cytomegalovirus using aminopeptidase
11/08/1995EP0680323A1 Synergising association having an antagonist effect on nk1 and nk2 receptors.
11/08/1995EP0680318A1 Method for increasing the efficiency of feed conversion in animals
11/08/1995EP0502143B1 Composition for treating ocular pain
11/08/1995CN1111454A Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
11/08/1995CN1111247A Protein kinase C inhibitors
11/08/1995CN1111127A Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
11/08/1995CN1111125A Liposome solutions
11/07/1995US5464872 Sleep disorders
11/07/1995US5464863 Anticholesterol agents
11/07/1995US5464861 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
11/07/1995US5464859 Benzospiroalkene derivatives
11/07/1995US5464858 Hypotensive
11/07/1995US5464849 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
11/07/1995US5464840 Tricyclic derivatives, compositions and methods of use
11/07/1995US5464834 N-substituted N'-heterobicyclic piperazines having pharmaceutical activity
11/07/1995US5464827 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors
11/07/1995US5464788 Tocolytic oxytocin receptor antagonists
11/06/1995CA2148666A1 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
11/06/1995CA2148650A1 Peptides derived from trifluoromethylketones; process for preparing the same and pharmaceutical compositions containing them
11/06/1995CA2148302A1 Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
11/04/1995CA2148324A1 Pyrrolopyrimidine derivatives having pharmacological activity
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029177A1 Tricyclic derivatives as 5ht2c and 5ht2b antagonists
11/02/1995WO1995029173A1 Naphthalene derivatives, method of preparation and use
11/02/1995WO1995029172A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes
11/02/1995WO1995029165A2 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors
11/02/1995WO1995029152A1 Benzamide derivatives as vasopressin antagonists
11/02/1995WO1995029148A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/02/1995WO1995028947A1 Permeabilizer peptides for increasing blood-ocular barrier permeability
11/02/1995WO1995028936A1 Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis
11/02/1995WO1995028931A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679659A1 Cathepsin-l-specific inhibitor polypeptide
1 ... 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 ... 1564